98%
921
2 minutes
20
The CHRNA5-CHRNA3-CHRNB4 gene cluster, encoding the α5, α3, and β4 nicotinic acetylcholine receptor (nAChR) subunits, has been linked to nicotine dependence. The habenulo-interpeduncular (Hb-IPN) tract is particularly enriched in α3β4 nAChRs. We recently showed that modulation of these receptors in the medial habenula (MHb) in mice altered nicotine consumption. Given that β4 is rate-limiting for receptor activity and that single nucleotide polymorphisms (SNPs) in CHRNB4 have been linked to altered risk of nicotine dependence in humans, we were interested in determining the contribution of allelic variants of β4 to nicotine receptor activity in the MHb. We screened for missense SNPs that had allele frequencies >0.0005 and introduced the corresponding substitutions in Chrnb4. Fourteen variants were analyzed by co-expression with α3. We found that β4A90I and β4T374I variants, previously shown to associate with reduced risk of smoking, and an additional variant β4D447Y, significantly increased nicotine-evoked current amplitudes, while β4R348C, the mutation most frequently encountered in sporadic amyotrophic lateral sclerosis (sALS), showed reduced nicotine currents. We employed lentiviruses to express β4 or β4 variants in the MHb. Immunoprecipitation studies confirmed that β4 lentiviral-mediated expression leads to specific upregulation of α3β4 but not β2 nAChRs in the Mhb. Mice injected with the β4-containing virus showed pronounced aversion to nicotine as previously observed in transgenic Tabac mice overexpressing Chrnb4 at endogenous sites including the MHb. Habenular expression of the β4 gain-of-function allele T374I also resulted in strong aversion, while transduction with the β4 loss-of function allele R348C failed to induce nicotine aversion. Altogether, these data confirm the critical role of habenular β4 in nicotine consumption, and identify specific SNPs in CHRNB4 that modify nicotine-elicited currents and alter nicotine consumption in mice.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902282 | PMC |
http://dx.doi.org/10.3389/fnhum.2014.00012 | DOI Listing |
Nurs Sci Q
October 2025
Department of Nursing, University of Massachusetts Boston, Boston, MA, USA.
Given nursing's interest in health policies, the authors present a discussion of costs associated with health policies. Three examples of these costs are adolescent use of vaping and e-cigarettes, international guidelines for hypertension diagnosis and treatment, and medical aid in dying.
View Article and Find Full Text PDFReprod Toxicol
September 2025
Department of Comparative Biosciences, University of Illinois Urbana-Champaign, Urbana, IL, USA. Electronic address:
Imidacloprid (IMI) is an insect-selective synthetic nicotine derivative used in commercial agricultural systems, home gardening, and veterinary pharmaceuticals. People are exposed to IMI through consumption of contaminated food and water and through contact with companion animals. However, the effects of IMI on the female reproductive system are not well understood.
View Article and Find Full Text PDFAm J Physiol Heart Circ Physiol
September 2025
Department of Physiology, University of Louisville School of Medicine, Louisville, KY.
Electronic cigarettes (E-cigs) are commonly presumed as a safer alternative to traditional cigarettes despite limited understanding of their health risks. This assumption may lead people, especially those in at-risk groups, to switch from traditional cigarettes to e-cigs, or to use e-cigs as their first form of nicotine consumption. Despite that pregnancy increases susceptibility to adverse cardiac events, a considerable fraction of pregnant women use e-cigs during gestation and postpartum.
View Article and Find Full Text PDFAddict Behav
September 2025
Rutgers School of Public Health, Piscataway, NJ, USA; Rutgers Institute for Nicotine and Tobacco Studies, New Brunswick, NJ, USA. Electronic address:
Introduction: Cannabis vape products (CVPs) have gained significant popularity as a method of cannabis consumption among U.S. young adults (YAs), raising concerns about associated health risks.
View Article and Find Full Text PDFHealth Promot J Austr
October 2025
Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
By 2025, all Australian jurisdictions will have a licensing scheme to manage the supply of tobacco. However, there is no national smoking product licensing framework to drive national consistency and enhance tobacco control. There are few published examples of the operation and impact of this tobacco control legislation.
View Article and Find Full Text PDF